Fulgent End Period Cash Flow from 2010 to 2025

FLGT Stock  USD 16.73  0.27  1.64%   
Fulgent Genetics End Period Cash Flow yearly trend continues to be comparatively stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2025. From the period from 2010 to 2025, Fulgent Genetics End Period Cash Flow quarterly data regression had r-value of  0.82 and coefficient of variation of  129.56. View All Fundamentals
 
End Period Cash Flow  
First Reported
2015-06-30
Previous Quarter
65.1 M
Current Value
58.2 M
Quarterly Volatility
73.9 M
 
Yuan Drop
 
Covid
Check Fulgent Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fulgent Genetics' main balance sheet or income statement drivers, such as Discontinued Operations of 49.5 K, Depreciation And Amortization of 31.6 M or Interest Expense of 44.7 M, as well as many indicators such as Price To Sales Ratio of 3.25, Dividend Yield of 0.018 or PTB Ratio of 0.83. Fulgent financial statements analysis is a perfect complement when working with Fulgent Genetics Valuation or Volatility modules.
  
Check out the analysis of Fulgent Genetics Correlation against competitors.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.

Latest Fulgent Genetics' End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Fulgent Genetics over the last few years. It is Fulgent Genetics' End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fulgent Genetics' overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
12.087.4164.79.597.5112.117.631%89%-52%23%15%5%100%
       Timeline  

Fulgent End Period Cash Flow Regression Statistics

Arithmetic Mean43,346,100
Geometric Mean5,354,403
Coefficient Of Variation129.56
Mean Deviation49,876,875
Median7,897,000
Standard Deviation56,157,407
Sample Variance3153.7T
Range164.7M
R-Value0.82
Mean Square Error1089.5T
R-Squared0.68
Significance0.00009
Slope9,709,332
Total Sum of Squares47304.8T

Fulgent End Period Cash Flow History

2025117.7 M
2024112.1 M
202397.5 M
202279.5 M
2021164.9 M
202087.4 M
201912 M

About Fulgent Genetics Financial Statements

Fulgent Genetics shareholders use historical fundamental indicators, such as End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Fulgent Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Fulgent Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Fulgent Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow112.1 M117.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fulgent Stock Analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.